Publications by authors named "Mark Mendonca"

Claim this Profile
T
Teclistamab is an active T cell-redirecting bispecific antibody against B-cell maturation antigen for multiple myeloma.
Kodandaram Pillarisetti, Gordon Powers, Leopoldo Luistro, Alexander Babich, Eric Baldwin

Blood Adv· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A T-cell-redirecting bispecific G-protein-coupled receptor class 5 member D x CD3 antibody to treat multiple myeloma.
Kodandaram Pillarisetti, Suzanne Edavettal, Mark Mendonça, Yingzhe Li, Mark Tornetta

Blood· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel C2 domain binding CD33xCD3 bispecific antibody with potent T-cell redirection activity against acute myeloid leukemia.
Priyanka Nair-Gupta, Michael Diem, Dara Reeves, Weirong Wang, Robert Schulingkamp

Blood Adv· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poor Antigen Processing of Poxvirus Particles Limits CD4 T Cell Recognition and Impacts Immunogenicity of the Inactivated Vaccine.
Katherine S Forsyth, Brian DeHaven, Mark Mendonca, Sinu Paul, Alessandro Sette

J Immunol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endogenous antigen processing drives the primary CD4+ T cell response to influenza.
Michael A Miller, Asha Purnima V Ganesan, Nancy Luckashenak, Mark Mendonca, Laurence C Eisenlohr

Nat Med· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytokine analysis by immunoaffinity capillary electrophoresis.
Mark Mendonca, Heather Kalish

Methods Mol Biol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis